Clinicopathological and Body Composition Analysis of VHL and TTN Gene Mutations in Clear Cell Renal Cell Carcinoma: An Exploratory Study

Clinicopathological and Body Composition Analysis of VHL and TTN Gene Mutations in Clear Cell Renal Cell Carcinoma: An Exploratory Study

Background: The Cancer Genome Atlas (TCGA) Research Network revealed numerous clear cell renal cell carcinoma (ccRCC) gene mutations among which titin (TTN). The link between excessive amounts of visceral adipose tissue (VAT) and ccRCC pathogenesis is known. A relationship between VHL and TTN gene m...

Full description

Bibliographic Details
Main Authors:	Federico Greco, Alessandro Tafuri, Rosario Francesco Grasso, Bruno Beomonte Zobel, Carlo Augusto Mallio
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	Applied Sciences
Subjects:	adipose tissue clear cell renal cell carcinoma kidney cancer muscle mass TTN VHL
Online Access:	https://www.mdpi.com/2076-3417/12/19/9502

Similar Items

Histological Tracking into the Third Dimension: Evolution of Early Tumorigenesis in VHL Kidney
by: Mayyan Mubarak, et al.
Published: (2021-09-01)

Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines
by: Xuechun Wang, et al.
Published: (2022-01-01)

VHL L169P Variant Does Not Alter Cellular Hypoxia Tension in Clear Cell Renal Cell Carcinoma
by: Junhui Hu, et al.
Published: (2023-09-01)

Radiogenomic Features of GIMAP Family Genes in Clear Cell Renal Cell Carcinoma: An Observational Study on CT Images
by: Federico Greco, et al.
Published: (2023-09-01)

Clear-cell renal cell carcinoma - A comprehensive review of agents used in the contemporary management of advanced/metastatic disease
by: Stavros Gkolfinopoulos, et al.
Published: (2021-02-01)

Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma
by: Maria F. Czyzyk-Krzeska, et al.
Published: (2021-03-01)

The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?
by: Alessandra Cinque, et al.
Published: (2022-10-01)

VHL mutation drives human clear cell renal cell carcinoma progression through PI3K/AKT-dependent cholesteryl ester accumulationResearch in context
by: Shuo Zhang, et al.
Published: (2024-05-01)

Subcutaneous Adipose Tissue Reduction in Patients with Clear Cell Renal Cell Carcinoma and Peritumoral Collateral Vessels: A Retrospective Observational Study
by: Federico Greco, et al.
Published: (2021-06-01)

Composition of Perinephric Fat and Fuhrman Grade in Clear Cell Renal Cell Carcinoma: The Role of Peritumoral Collateral Vessels
by: Federico Greco, et al.
Published: (2021-04-01)

Delayed Cardiac Metastasis from Renal Cell Carcinoma Caused by VHL Mutation
by: Christopher L. Sudduth, et al.
Published: (2023-02-01)

Spectrum of VHL mutations in clear cell renal cell carcinoma
by: N. N. Mazurenko, et al.
Published: (2020-11-01)

Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel–Lindau-Disease-Associated Tumors
by: Cristina Suárez, et al.
Published: (2023-06-01)

Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance
by: Sonia Mazumder, et al.
Published: (2023-02-01)

Exploring TTN variants as genetic insights into cardiomyopathy pathogenesis and potential emerging clues to molecular mechanisms in cardiomyopathies
by: Amir Ghaffari Jolfayi, et al.
Published: (2024-03-01)

The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis
by: Petra Hudler, et al.
Published: (2022-02-01)

Complete remission of Hodgkin’s lymphoma in a pediatric patient with TTN gene mutation treated with brentuximab vedotin combined chemotherapy without anthracyclines: A case report
by: Ying Li, et al.
Published: (2022-10-01)

Circular Intronic RNA circTTN Inhibits Host Gene Transcription and Myogenesis by Recruiting PURB Proteins to form Heterotypic Complexes
by: Nini Ai, et al.
Published: (2023-06-01)

The role of miRNA genes participating in VHL-HIF1α in clear cell renal cell carcinoma
by: V. N. Pavlov, et al.
Published: (2019-02-01)

Prognostic significance of long noncoding RNA TTN‐AS1 in various malignancies
by: Guangyao Lin, et al.
Published: (2023-10-01)

A novel TTN deletion in a family with skeletal myopathy, facial weakness, and dilated cardiomyopathy
by: Jennifer Roggenbuck, et al.
Published: (2019-11-01)

Whole-Exome Sequencing Identifies the VHL Mutation (c.262T > C, p.Try88Arg) in Non-Obstructive Azoospermia-Associated Cystic Renal Cell Carcinoma
by: Yonghong Man, et al.
Published: (2022-03-01)

Two novel mutations in TTN of a patient with congenital myopathy: A case report
by: Joon Young Jang, et al.
Published: (2019-08-01)

Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHL
by: Aileen Arevalo, et al.
Published: (2022-09-01)

A novel mutation in the TTN gene resulted in left ventricular noncompaction: a case report and literature review
by: Shipeng Tian, et al.
Published: (2023-07-01)

Heterogeneous pattern of gene expression driven by TTN mutation is involved in the construction of a prognosis model of lung squamous cell carcinoma
by: Zhao Liu, et al.
Published: (2023-03-01)

Two Single Nucleotide Polymorphisms in the Von Hippel-Lindau Tumor Suppressor Gene in Patients with Clear Cell Renal Cell Carcinoma
by: Magdalena Chrabańska, et al.
Published: (2023-02-01)

High VHL Expression Reverses Warburg Phenotype and Enhances Immunogenicity in Kidney Tumor Cells
by: Songbiao Zhu, et al.
Published: (2022-08-01)

TTN as a candidate gene for distal arthrogryposis type 10 pathogenesis
by: Anik Biswas, et al.
Published: (2022-08-01)

VHL-dependence of EHHADH Expression in a Human Renal Cell Carcinoma Cell Line
by: Julia Felicitas Pilz, et al.
Published: (2024-01-01)

Centronuclear myopathy due to a de novo nonsense variant and a maternally inherited splice‐site variant in TTN: A case report
by: Sheng Huang, et al.
Published: (2021-07-01)

UBE2S promotes malignant properties via VHL/HIF‐1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma
by: Junyi Wu, et al.
Published: (2023-09-01)

Novel and recurrent genetic variants of VHL, SDHB, and RET genes in Chinese pheochromocytoma and paraganglioma patients
by: Chong Li, et al.
Published: (2023-03-01)

Identification and validation of a TTN-associated immune prognostic model for skin cutaneous melanoma
by: Qirui Wang, et al.
Published: (2023-01-01)

The roles of VHL-dependent ubiquitination in signaling and cancer
by: Qing eZhang, et al.
Published: (2012-04-01)

Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors
by: Krisztián Szegedi, et al.
Published: (2023-07-01)

Relationship between Androgen Deprivation Therapy and Abdominal Adipose Tissue
by: Federico Greco, et al.
Published: (2022-12-01)

Clear Cell Acanthoma with Malignant Cytologic Features: A Case Report and Review of the Literature
by: Gabriella Melson, et al.
Published: (2022-10-01)

Pathogenic Variant Rs1471414348of the TTN Gene in the Patient with Familial Left Venticular Noncompaction Cardiomyopathy
by: O. V. Kulikova, et al.
Published: (2019-09-01)

The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma
by: Amrita M. Nargund, et al.
Published: (2017-03-01)